Abstract
Alterations of commensal flora may cause various gastrointestinal and extraintestinal diseases, including food intolerances and food allergies. According to the ‘microflora hypothesis’, alterations in the composition of gut microbiota in industrialized countries have disturbed the mechanisms of mucosal immune tolerance. Over the past few years several studies have looked for a role for probiotics in the treatment of food allergies with promising results.
References
1.
Van Vliet MJ, Harmsen HJ, de Bont ES, Tissing WJ: The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis. PLoS Pathog 2010;6:e1000879.
2.
Sharma R, Young C, Neu J: Molecular modulation of intestinal epithelial barrier: contribution of microbiota. J Biomed Biotechnol 2010;2010:305879.
3.
Brandtzaeg P: Food allergy: separating the science from the mythology. Nat Rev Gastroenterol Hepatol 2010;7:380–400.
4.
Kim YS, Ho SB: Intestinal goblet cell and mucins in health and disease: recent insights and progress. Curr Gastroenterol Rep 2010;12:319–330.
5.
Renz-Polster H, David MR, Buist AS, Vollmer WM, O’Connor EA, Frazier EA, Wall MA: Caesarean section delivery and the risk of allergic disorders in childhood. Clin Exp Allergy 2005;35:1466–1472.
6.
Eggesbø M, Botten G, Stigum H, Nafstad P, Magnus P: Is delivery by cesarean section a risk factor for food allergy? J Allergy Clin Immunol 2003;112:420–426.
7.
Koplin J, Allen K, Gurrin L, Osborne N, Tang ML, Dharmage S: Is caesarean delivery associated with sensitization to food allergens and IgE-mediated food allergy: a systematic review. Pediatr Allergy Immunol 2008;19:682–687.
8.
Ouwehand AC: Antiallergic effects of probiotics. J Nutr 2007;137(3 suppl 2):794S–797S.
9.
Von der Weid T, Bulliard C, Schiffrin EJ: Induction by a lactic acid bacterium of a population of CD4(+) T cells with low proliferative capacity that produce transforming growth factor beta and interleukin-10. Clin Diagn Lab Immunol 2001;8:695–701.
10.
Kirjavainen PV, Gibson GR: Healthy gut microflora and allergy: factors influencing development of the microbiota. Ann Med 1999;31:288–292.
11.
Mogensen TH: Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev 2009;22:240–273, table of contents.
12.
Patriarca G, Nucera E, Roncallo C, Aruanno A, Lombardo C, Decinti M, Pascolini L, Milani M, Buonomo A, Schiavino D: Sublingual immunotherapy with venom for patients with Hymenoptera venom allergy. J Allergy Clin Immunol 2009;124:385, author reply 385–386.
13.
Wang J, Sampson HA: Food allergy: recent advances in pathophysiology and treatment. Allergy Asthma Immunol Res 2009;1:19–29.
14.
Burks AW, Laubach S, Jones SM. Oral tolerance, food allergy, and immunotherapy: implications for future treatment. J Allergy Clin Immunol 2008;121:1344–1350.
15.
Kunisawa J, Kiyono H: Aberrant interaction of the gut immune system with environmental factors in the development of food allergies. Curr Allergy Asthma Rep 2010;10:215–221.
16.
Umetsu DT, McIntire JJ, Akbari O, Macaubas C, DeKruyff RH: Asthma: an epidemic of dysregulated immunity Nat Immunol 2002;3:715–720.
17.
Wills-Karp M, Santeliz J, Karp CL: The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat Rev Immunol 2001;1:69–75.
18.
Strachan DP: Hay fever, hygiene, and household size. BMJ 1989;299:1259–1260.
19.
Noverr MC, Huffnagle GB: The ‘microflora hypothesis’ of allergic diseases. Clin Exp Allergy 2005;35:1511–1520.
20.
Penders J, Stobberingh EE, van den Brandt PA, Thijs C: The role of the intestinal microbiota in the development of atopic disorders. Allergy 2007;62:1223–1236.
21.
Huffnagle GB: The microbiota and allergies/asthma. PLoS Pathog 2010;6:e1000549.
22.
Rodriguez B, Prioult G, Bibiloni R, Nicolis I, Mercenier A, Butel MJ, Waligora-Dupriet AJ: Germ-free status and altered caecal subdominant microbiota are associated with a high susceptibility to cow’s milk allergy in mice. FEMS Microbiol Ecol 2011;76:133–144.
23.
Bjorksten B: The gut microbiota: a complex ecosystem. Clin Exp Allergy 2006;36:1215–1217.
24.
Björkstén B, Sepp E, Julge K, Voor T, Mikelsaar M: Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol 2001;108:516–520.
25.
Murray CS, Tannock GW, Simon MA, Harmsen HJ, Welling GW, Custovic A, Woodcock A: Fecal microbiota in sensitized wheezy and non-sensitized non-wheezy children: a nested case-control study. Clin Exp Allergy 2005;35:741–745.
26.
He F, Morita H, Hashimoto H, Hosoda M, Kurisaki J, Ouwehand AC, Isolauri E, Benno Y, Salminen S: Intestinal Bifidobacterium species induce varying cytokine production. J Allergy Clin Immunol 2002;109:1035–1036.
27.
Lee YK, Mazmanian SK: Has the microbiota played a critical role in the evolution of the adaptive immune system? Science 2010;330:1768–1773.
28.
Round JL, Mazmanian SK: The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 2009;9:313–323.
29.
Wright EM, Martín MG, Turk E: Intestinal absorption in health and disease – sugars. Best Pract Res Clin Gastroenterol 2003; 17:943–956.
30.
Lin HC: Small intestinal bacterial overgrowth: a framework for understanding irritable bowel syndrome. JAMA 2004;292:852–858.
31.
Sudo N, Sawamura S, Tanaka K, Aiba Y, Kubo C, Koga Y: The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol 1997;159:1739–1745.
32.
Sherman PM, Cabana M, Gibson GR, Koletzko BV, Neu J, Veereman-Wauters G, Ziegler EE, Walker WA: Potential roles and clinical utility of prebiotics in newborns, infants, and children: proceedings from a global prebiotic summit meeting, New York City, June 27–28, 2008. J Pediatr 2009;155:S61–S70.
33.
Grönlund MM, Gueimonde M, Laitinen K, Kociubinski G, Grönroos T, Salminen S, Isolauri E: Maternal breast-milk and intestinal bifidobacteria guide the compositional development of the Bifidobacterium microbiota in infants at risk of allergic disease. Clin Exp Allergy 2007;37:1764–1772.
34.
Fanaro S, Vigi V: Which role for prebiotics at weaning? J Clin Gastroenterol 2008;42(suppl 3):S209–S213.
35.
Marschan E, Kuitunen M, Kukkonen K, Poussa T, Sarnesto A, Haahtela T, Korpela R, Savilahti E, Vaarala O: Probiotics in infancy induce protective immune profiles that are characteristic for chronic low-grade inflammation. Clin Exp Allergy 2008;38:611-618.
36.
Kukkoken K, Kuitunen M, Haahtela T, Korpela R, Poussa T, Savilahti E: High intestinal IgA associates with reduced risk of IgE-associated allergic diseases. Pediatr Allergy Immunol 2010;21:67–73.
37.
Savilhati E, Kuitunen M, Vaarala O: Pre and probiotics in the prevention and treatment of food allergy. Curr Opin Allergy Clin Immunol 2008;8:243–248.
38.
Viljanen M, Pohjavuori E, Haahtela T, Korpela R, Kuitunen M, Sarnesto A, Vaarala O, Savilahti E: Induction of inflammation as a possible mechanism of probiotic effect in atopic eczema-dermatitis syndrome. J Allergy Clin Immunol 2005;115:1254–1259.
39.
Pohjavuori E, Viljanen M, Korpela R, Kuitunen M, Tiittanen M, Vaarala O, Savilahti E: Lactobacillus GG effect in increasing IFN-gamma production in infants with cow’s milk allergy. J Allergy Clin Immunol 2004;114:131–136.
40.
Isolauri E, Salminen S, Nutrition, Allergy, Mucosal Immunology, and Intestinal Microbiota (NAMI) Research Group Report: Probiotics: use in allergic disorders: a Nutrition, Allergy, Mucosal Immunology, and Intestinal Microbiota (NAMI) Research Group Report. J Clin Gastroenterol 2008;42(suppl 2):S91–S96.
41.
Smits HH, Engering A, van der Kleij D, de Jong EC, Schipper K, van Capel TM, Zaat BA, Yazdanbakhsh M, Wierenga EA, van Kooyk Y, Kapsenberg ML: Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J Allergy Clin Immunol 2005;115:1260–1267.
42.
Lammers KM, Brigidi P, Vitali B, Gionchetti P, Rizzello F, Caramelli E, Matteuzzi D, Campieri M: Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells. FEMS Immunol Med Microbiol 2003;38:165–172.
43.
Isolauri E, Arvola T, Sütas Y, Moilanen E, Salminen S: Probiotics in the management of atopic eczema. Clin Exp Allergy 2000;30:1604–1610.
44.
Rosenfeldt V, Benfeldt E, Nielsen SD, Michaelsen KF, Jeppesen DL, Valerius NH, Paerregaard A: Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol 2003;111:389–395.
45.
Torii A, Torii S, Fujiwara S, Tanaka H, Inagaki N, Nagai H. Lactobacillus Acidophilus strain L-92 regulates the production of Th1 cytokine as well as Th2 cytokines. Allergol Int 2007;56:293–301.
46.
Abrahamsson TR, Jakobsson T, Böttcher MF, Fredrikson M, Jenmalm MC, Björkstén B, Oldaeus G: Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol 2007;119:1174–1180.
47.
Kuitunen M, Kukkonen K, Juntunen-Backman K, Korpela R, Poussa T, Tuure T, Haahtela T, Savilahti E: Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort. J Allergy Clin Immunol 2009;123:335–341.
48.
Brouwer ML, Wolt-Plompen SA, Dubois AE, van der Heide S, Jansen DF, Hoijer MA, Kauffman HF, Duiverman EJ: No effects of probiotics on atopic dermatitis in infancy: a randomized placebo-controlled trial. Clin Exp Allergy 2006;36:899–906.
49.
Taylor AL, Dunstan JA, Prescott SL: Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial. J Allergy Clin Immunol 2007;119:184–191.
50.
Tulic MK, Fiset PO, Manoukian JJ, Frenkiel S, Lavigne F, Eidelman DH, Hamid Q: Role of toll-like receptor 4 in protection by bacterial lipopolysaccharide in the nasal mucosa of atopic children but not adults. Lancet 2004;363:1689–1697.
51.
Majamaa H, Isolauri E, Saxelin M, Vesikari T: Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J Pediatr Gastroenterol Nutr 1995;20:333–338.
52.
Pessi T, Sutas Y, Martiinen A, Isolauri E: Probiotics reinforce mucosal degradation of antigens in rats: implications for therapeutic use of probiotics. J Nutr 1998;128:2313–2318.
53.
Bibiloni R, Schiffrin EJ: Intestinal host-microbe interactions under physiological and pathological conditions. Int J Inflam 2010;2010:386956.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.